EKF DIAGNOSTICS HOLDINGS PLC (EKF) — Interim results for the six months ended 30 June 2026

Investor webinar replay

Replay transcript excerpt

Speaker 1: Good afternoon and welcome to the EKF Diagnostics Holdings PLC Investor Presentation. Speaker 1: Throughout this recorded presentation, investors will be in a listen-only mode. Questions are encouraged and could be submitted at any time via the Q&A tab situated on the right-hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself, however the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to Gavin Jones, CEO. Good afternoon, sir. Speaker 2: Thank you very much. Speaker 2: Good afternoon, everyone, Speaker 2: and thank you for joining us. As I already said, I'm Gavin Green, Speaker 2: CEO Speaker 2: at EKF, and I'm joined today by Helen Jones, our new CFO. Speaker 2: We're pleased to walk you through a solid set of interim results for the 1st 0.5 of 2026 Speaker 2: and update you on the progress we're making against our five-year strategy. Speaker 2: For anyone Speaker 2: newer Speaker 2: to the EKF story, we operate across 2 complementary divisions, Speaker 2: point of care, Speaker 2: where we manufacture diagnostic Speaker 2: devices Speaker 2: and tests that deliver rapid, Speaker 2: accurate results Speaker 2: right where they're needed at or near the patient. This is distributed Speaker 2: through our global partner network reaching over 120 Speaker 2: countries. Speaker 2: Our life sciences division supplies high quality reagents, enzymes Speaker 2: and contract manufacturing Speaker 2: services Speaker 2: that help Speaker 2: companies out there bring their own products to market across pharma,...